Sweetening up yeast glycoprotein synthesis

Area of Science:

• Biotechnology
• Molecular Biology
• Synthetic Biology

Background:

• Protein glycosylation is a crucial post-translational modification essential for protein function and stability.
• Current methods for producing human glycoproteins in yeast often result in incomplete or incorrect glycosylation patterns.
• The ability to replicate human glycosylation in a heterologous host is highly desirable for biopharmaceutical production.

Purpose of the Study:

• To engineer a yeast strain capable of performing the complete human protein glycosylation pathway.
• To establish a robust and scalable platform for the production of human glycoproteins with native-like structures.

Main Methods:

• Genetic engineering of Saccharomyces cerevisiae to introduce and optimize human glycosylation enzymes.
• Metabolic pathway engineering to redirect precursor supply for human-like glycan synthesis.
• High-throughput screening and characterization of engineered yeast strains.

Main Results:

• The engineered yeast strain successfully executed the full spectrum of human N-linked protein glycosylation reactions.
• Characterization confirmed the production of human-like N-glycans on recombinant proteins expressed in the engineered yeast.
• The platform demonstrated scalability and reproducibility in producing correctly glycosylated proteins.

Conclusions:

• This engineered yeast strain represents a significant advancement in glycosylation engineering.
• The developed platform offers a powerful tool for the biopharmaceutical industry to produce complex glycoproteins with enhanced therapeutic efficacy.
• Further optimization holds promise for producing a wider array of humanized glycoproteins.